These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 9494773)

  • 21. Acceptability and performance of a nonwoven device for vaginal drug delivery among women and their male partners in KwaZulu-Natal, South Africa.
    Hart CW; Joanis C; Hartmann M; Milford C; Smit J; Beksinska M; Rambally-Greener L; Pienaar J; Mabude Z; Butterworth GAM; Sokal D; Jenkins D
    Eur J Contracept Reprod Health Care; 2019 Oct; 24(5):390-398. PubMed ID: 31517545
    [No Abstract]   [Full Text] [Related]  

  • 22. Can you bet your life on a condom?
    Pac AIDS Alert Bull; 1997 Sep; (13):8-9. PubMed ID: 12293128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase 1 trial of nonoxynol-9 film among sex workers in South Africa.
    Rustomjee R; Abdool Karim Q; Abdool Karim SS; Laga M; Stein Z
    AIDS; 1999 Aug; 13(12):1511-5. PubMed ID: 10465075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spermicides for family planning and disease protection: an update.
    Townsend S
    Netw Res Triangle Park N C; 1991 Dec; 12(3):23-6. PubMed ID: 12284758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Seventeen-year review of sexual and contraceptive behavior on a college campus.
    Hale RW; Char DF; Nagy K; Stockert N
    Am J Obstet Gynecol; 1993 Jun; 168(6 Pt 1):1833-7; discussion 1837-8. PubMed ID: 8317529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determinants of cervical ectopia and of cervicitis: age, oral contraception, specific cervical infection, smoking, and douching.
    Critchlow CW; Wölner-Hanssen P; Eschenbach DA; Kiviat NB; Koutsky LA; Stevens CE; Holmes KK
    Am J Obstet Gynecol; 1995 Aug; 173(2):534-43. PubMed ID: 7645632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cervicovaginal colposcopic lesions associated with 5 nonoxynol-9 vaginal spermicide formulations.
    Harwood B; Meyn LA; Ballagh SA; Raymond EG; Archer DF; Creinin MD
    Am J Obstet Gynecol; 2008 Jan; 198(1):32.e1-7. PubMed ID: 18166301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaginal gel formulation based on theaflavin derivatives as a microbicide to prevent HIV sexual transmission.
    Yang J; Li L; Jin H; Tan S; Qiu J; Yang L; Ding Y; Jiang ZH; Jiang S; Liu S
    AIDS Res Hum Retroviruses; 2012 Nov; 28(11):1498-508. PubMed ID: 22867271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First-in-Human Trial of MIV-150 and Zinc Acetate Coformulated in a Carrageenan Gel: Safety, Pharmacokinetics, Acceptability, Adherence, and Pharmacodynamics.
    Friedland BA; Hoesley CJ; Plagianos M; Hoskin E; Zhang S; Teleshova N; Alami M; Novak L; Kleinbeck KR; Katzen LL; Zydowsky TM; Fernández-Romero JA; Creasy GW
    J Acquir Immune Defic Syndr; 2016 Dec; 73(5):489-496. PubMed ID: 27437826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acceptability of a carrageenan-based candidate vaginal microbicide and matching placebo: findings from a phase II safety trial among women in Chiang Rai, Thailand.
    Jones HE; Chaikummao S; van de Wijgert JH; Friedland BA; Manopaiboon C; Witwatwongwana P; Wankrairot M; Chantharojwong N; Kilmarx PH
    J Womens Health (Larchmt); 2009 Jul; 18(7):1003-10. PubMed ID: 19575689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acceptability of a new intravaginal barrier contraceptive device (Femcap).
    Shihata AA; Gollub E
    Contraception; 1992 Dec; 46(6):511-9. PubMed ID: 1493711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Zinc acetate/carrageenan gels exhibit potent activity in vivo against high-dose herpes simplex virus 2 vaginal and rectal challenge.
    Fernández-Romero JA; Abraham CJ; Rodriguez A; Kizima L; Jean-Pierre N; Menon R; Begay O; Seidor S; Ford BE; Gil PI; Peters J; Katz D; Robbiani M; Zydowsky TM
    Antimicrob Agents Chemother; 2012 Jan; 56(1):358-68. PubMed ID: 22064530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expanded Phase I safety and acceptability study of 6% cellulose sulfate vaginal gel.
    Malonza IM; Mirembe F; Nakabiito C; Odusoga LO; Osinupebi OA; Hazari K; Chitlange S; Ali MM; Callahan M; Van Damme L
    AIDS; 2005 Dec; 19(18):2157-63. PubMed ID: 16284466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microbicides research and the woman's perspective.
    Barnett B
    Netw Res Triangle Park N C; 1995 Sep; 16(1):17. PubMed ID: 12290466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preventing HIV transmission in "priority" countries.
    Finger WR
    Netw Res Triangle Park N C; 1993 May; 13(4):18-21. PubMed ID: 12344871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a Vaginal Fast-Dissolving Insert Combining Griffithsin and Carrageenan for Potential Use Against Sexually Transmitted Infections.
    Lal M; Lai M; Ugaonkar S; Wesenberg A; Kizima L; Rodriguez A; Levendosky K; Mizenina O; Fernández-Romero J; Zydowsky T
    J Pharm Sci; 2018 Oct; 107(10):2601-2610. PubMed ID: 29902477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The female condom tested.
    AIDS Health Promot Exch; 1992; (4):6. PubMed ID: 12318244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluating the clinical safety of three vaginal applicators: a pilot study conducted in the Dominican Republic.
    Brache V; Cohen JA; Cochon L; Alvarez F
    Contraception; 2006 Jan; 73(1):72-7. PubMed ID: 16371299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. STD studies show spermicides protect against Chlamydia.
    Netw Res Triangle Park N C; 1986; 7(2):4. PubMed ID: 12340620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study of the abnormal cervical-vaginal cytology of sexually active young women living within the Waterloo region.
    Redmond M; Schumacher B
    Can J Public Health; 1990; 81(3):235-6. PubMed ID: 2361216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.